Bright Green To Supply DEA-Approved Cannabis Extracts And Psychedelics To FDA-Registered Pharmaceutical Company
Portfolio Pulse from Nina Zdinjak
Bright Green Corporation (NASDAQ:BGXX) has signed a letter of intent to supply DEA-approved cannabis extracts and psychedelics to Benuvia Operations, an FDA-registered pharmaceutical company. This agreement positions Bright Green as a leading supplier of plant-based raw materials for cannabinoid, psychedelic, and opioid-based drugs in the USA.
August 22, 2024 | 3:39 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bright Green Corporation has signed a letter of intent to supply DEA-approved cannabis extracts and psychedelics to Benuvia Operations, enhancing its position in the pharmaceutical supply chain.
The LOI with Benuvia Operations is a significant step for Bright Green, as it aligns with their strategy to become a leading supplier of DEA-controlled plant-based materials. This partnership could enhance their market position and drive future growth, as indicated by the 2.6% increase in share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100